Overview

Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer

Status:
Unknown status

Trial end date:
2018-02-01

Target enrollment:

Participant gender:

Summary

The primary aim of this french multicenter national study is to assess and compare time to quality of life score deterioration (targeted dimensions : global health, fatigue and emotional functionning of EORTC QLQC30 according to the first line chemotherapy associated with bevacizumab in metastatic colorectal patients.

Details

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Treatments:

Bevacizumab
Irinotecan
Oxaliplatin